FUSN - Fusion Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FUSN is currently covered by 5 analysts with an average price target of $28.48. This is a potential upside of $6.93 (32.16%) from yesterday's end of day stock price of $21.55.

Fusion Pharmaceuticals 's activity chart (see below) currently has 7 price targets and 21 ratings on display. The stock rating distribution of FUSN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.56% with an average time for these price targets to be met of 210 days.

Highest price target for FUSN is $16, Lowest price target is $13, average price target is $28.48.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 26-Jan-2024. First documented stock forecast 21-Jul-2020.

Best performing analysts who are covering FUSN - Fusion Pharmaceuticals :

Matthew Harrison Yuan Zhi Rahul Sarugaser David Nierengarten Nicole Germino John Walsh

Currently out of the existing stock ratings of FUSN, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$-8.55 (-39.68%)

$13

10 months 22 days ago
(26-Jan-2024)

2/3 (66.67%)

$2.11 (19.38%)

131

Buy

$16

$-5.55 (-25.75%)

$15

11 months 13 days ago
(05-Jan-2024)

4/4 (100%)

$7.65 (91.62%)

143

Buy

$13

$-8.55 (-39.68%)

$10

1 years 2 months 15 days ago
(03-Oct-2023)

3/3 (100%)

$9.78 (303.73%)

287

Buy

$10

$-11.55 (-53.60%)

1 years 10 months 21 days ago
(27-Jan-2023)

2/3 (66.67%)

$6.75 (207.69%)

699

Buy

$10

$5.68 (131.48%)

2 years 3 months 2 days ago
(16-Sep-2022)

0/1 (0%)

$7 (233.33%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?

On average it took 210 days on average for the stock forecasts to be realized with a an average price target met ratio 55.56

Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

JOHN WALSH

Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison works at MORGAN STANLEY and has 8 price targets and 5 ratings on FUSN

Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?

Nicole Germino with highest potential upside - $5.68

Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison with lowest potential downside - -$11.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?